Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II)
Authors: R J Aspinall, M Hudson, S D Ryder, P Richardson, E Farrington, M Wright, R T Przemioslo, F Perez, M Kent, R Henrar, J Hickey, D L Shawcross